Executing Successful Psychedelic Studies from Protocol to Patient, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how psychedelic clinical trials can be designed and executed to address their unique operational and assessment challenges. The featured speakers will discuss trial design, site-level execution and data collection strategies, including considerations around blinding, psychotherapy assistance and prior psychedelic use. Attendees will also explore how early collaboration with experienced CRO and site partners can strengthen study execution and support reliable results.

TORONTO, Oct. 6, 2026 /PRNewswire/ -- Psychedelic clinical trials present unique challenges that can make successful execution fundamentally different from small molecules. The psychedelic experience, blinding, psychotherapy assistance and previous use, for example, introduce complexity that sponsors need to address early in the development process. Experienced cross-functional teams and sites with the right medical expertise, infrastructure and capabilities can help sponsors navigate these challenges.

In this webinar, the featured speakers will share complementary perspectives from CRO and site network organizations on what it takes to successfully design and execute psychedelic trials. The discussion will focus on three critical areas: translating the unique characteristics of psychedelics into thoughtful trial design, operationalizing complex studies at the site level and developing assessment strategies that support reliable and meaningful data. By bringing these perspectives together, the webinar will highlight strategies for anticipating challenges, strengthening study execution and building effective partnerships from the outset.

Ultimately, successful psychedelic development depends not only on a well-designed protocol, but on early collaboration with experienced partners who understand how to bring that protocol to life.

Register for this webinar to learn how psychedelic studies can be designed and executed to address trial complexity and support reliable study outcomes.

Join experts from Premier Research, Andreas Schreiner, MD, Senior Vice President, Medical Affairs, Neuroscience & Analgesia; and Rishi Kakar, MD, Chief Scientific Officer and Medical Director at Segal Trials, for the live webinar on Thursday, October 22, 2026, at 11am EDT (5pm CEST / EU-Central).

For more information, or to register for this event, visit Executing Successful Psychedelic Studies from Protocol to Patient.

ABOUT XTALKS

Xtalks – The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.

Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what's next.

To learn more about Xtalks, visit www.xtalks.com
For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/

Contact:
Soumya Shashikumar
Tel: +1 (416) 977-6555 x371
Email: [email protected]

SOURCE Xtalks